Manager of Strategic Accounts - 2585

Pleural Dynamics is an early-stage medical device company commercializing ACES, an implantable shunt that passively moves fluid from the pleural space into the abdomen, giving late-stage cancer patients a fully internal, maintenance-free alternative to external drainage catheters they'd otherwise manage multiple times a week at home. The technology is 510(k)-cleared, reimbursement is in place, and marquee institutions are already coming on board. For the right candidate, this is a rare chance to get in early on a paradigm-shifting technology with real acquisition upside and the kind of career-defining impact that only comes from building something from the ground up.

• You're selling a product that genuinely gives terminally ill patients their life back.
• The hard part is done; cleared device, reimbursement in place, and marquee institutions already on board. You're joining at the best possible time.
• The upside is real - uncapped commission, stock options in a company with active acquisition interest, and a resume moment that doesn't come around often.
• Has a background in thoracic surgery, IP, or interventional pulmonology and can earn physician trust quickly.
• Is startup-minded, self-directed, and energized by opening new accounts rather than managing an established book, with a track record of launching new technology.
• Can manage a varied geography independently, and bring existing relationships that can accelerate early adoption of a first-of-its-kind device.